DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Launched by OHIO STATE UNIVERSITY · Apr 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The DIAMOND study is looking to understand how older adults are treated in emergency departments, especially when they are having mental health issues or problems with movement. Researchers want to find out how often these patients receive medications called antipsychotics or benzodiazepines, which are sometimes used to help with behavior and anxiety but can also have risks. They will compare the usual treatment practices with new guidelines to see if following these guidelines can help reduce the use of these medications, especially in patients who might have cognitive disorders, like dementia, or movement disorders.
To be eligible for this study, you need to be over 54 years old and have received antipsychotics or benzodiazepines during your visit to the emergency department, along with showing signs of cognitive or movement issues. If you participate, the study will help researchers gather important information that could improve care for older adults in emergency situations. The study is not yet recruiting participants, but it aims to shed light on better medication practices for the health and safety of older patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 54
- • Received antipsychotic/benzodiazepine in the ED
- • Have clinical signs or symptoms of underlying cognitive or movement disorders
- Exclusion Criteria:
- • None
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported